(Q45221608)
Statements
1 reference
Cost-minimization analysis of fingolimod compared with natalizumab for the treatment of relapsing-remitting multiple sclerosis in Sweden (English)
1 reference
Niklas Bergvall
1 reference
Magnus Tambour
1 reference
Freddie Henriksson
1 reference
Sten Fredrikson
1 reference
18 December 2012
1 reference
1 reference
16
1 reference
3
1 reference
349-357
1 reference
Identifiers
1 reference
1 reference